SCHEMBL5013682

SCHEMBL5013682

N[C@@H](Cc1ccc(OC(=O)N2CCC2)cc1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.55
▸ POLB P06746 1/20 0.55
▸ MEN1 O00255 5/20 0.50
▸ KMT2A Q03164 5/20 0.50
▸ SMN1; SMN2 Q16637 5/20 0.50
▸ SLC7A5 Q01650 3/20 0.50
▸ LMNA P02545 2/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ PTPN1 P18031 1/20 0.50
▸ NPC1 O15118 2/20 0.49
▸ ITGB3 P05106 1/20 0.49
▸ ITGA2B P08514 1/20 0.49
▸ PTGS1 P23219 2/20 0.49
▸ ALPI P09923 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ XIAP P98170 1/20 0.49
▸ MAPT P10636 3/20 0.46
▸ HTT P42858 2/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ CYP3A4 P08684 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2951695 0.97 ALDH1A1 (0.59) ALDH1A1POLBMEN1KMT2ASMN1; SMN2
SCHEMBL5009929 0.96 ALDH1A1 (0.62) ALDH1A1POLBMEN1KMT2ASMN1; SMN2
SCHEMBL8060168 0.88 ITGB1 (0.57) ALDH1A1POLBSLC7A5PTPN1ITGB3
SCHEMBL8058266 0.88 PTPN1 (0.47) ALDH1A1POLBMEN1KMT2ASMN1; SMN2
SCHEMBL21689918 0.88 KMT2A (0.58) ALDH1A1MEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL2857963 0.88 ITGB1 (0.57) ALDH1A1POLBSLC7A5PTPN1ITGB3
SCHEMBL8058263 0.88 PTPN1 (0.47) ALDH1A1POLBMEN1KMT2ASMN1; SMN2
SCHEMBL21690440 0.88 KMT2A (0.58) ALDH1A1MEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL17822347 0.83 ALDH1A1 (0.55) ALDH1A1POLBMEN1KMT2ASMN1; SMN2
SCHEMBL17822346 0.83 ALDH1A1 (0.55) ALDH1A1POLBMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007392-A2 METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH ALPHA-4 INHIBITORY COMPOUNDS ELAN PHARMACEUTICALS, INC. (US) 2008-12-31 — — EP disclosed
WO-2007100763-A2 METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH ALPHA-4 INHIBITORY COMPOUNDS ELAN PHARMACEUTICALS, INC. (US) 2007-09-07 — — WO disclosed
Send feedback